An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia
Open Access
- 20 April 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genetics
- Vol. 19 (1), 64
- https://doi.org/10.1186/s12881-018-0566-0
Abstract
Short-chain acyl-CoA dehydrogenase deficiency (SCADD) represents a rare autosomal recessive inborn metabolic disorder of mitochondrial β-oxidation of monocarboxylic acids. Clinical symptoms can vary from a severe life-threatening condition to an asymptomatic state, reported in the majority of cases. Since the expansion of newborn screenings, more than three hundred probands were admitted for molecular-genetic analysis, most selected because of elevated values of C4-acylcarnitine detected in newborn screenings in Slovakia. Searching for the principal genomic changes led us to the selection of sixty-two patients in whom the presence of sequence variants in the ACADS gene was analysed and correlated with the available biochemical and clinical data. Biochemical and molecular genetic tests were performed. Acylcarnitine profiles focused on an elevated level of C4-acylcarnitine, which was analysed via tandem mass spectrometry. Urinary organic acids, specifically a quantity of ethylmalonic acid, were determined by gas chromatography/mass spectrometry. The entire coding region of the ACADS gene was sequenced. A low-cost restriction fragment length polymorphism of PCR amplified fragments analysis (PCR-RFLP) of pathogenic variants was introduced and implemented for the molecular-genetic algorithm appropriate for the Slovak population. Our molecular genetic study was performed on sixty-two patients with a pathological biochemical pattern related to short-chain acyl-CoA dehydrogenase deficiency. In this cohort, we discovered a high occurrence of two rare pathogenic variants—the deletion c.310_312delGAG and the substitution c.1138C>T, with allelic frequencies of 64% and 31%, respectively. Up to 86% of investigated individuals belong to the Roma ethnic group. Analogous to other countries, SCADD is not included in the newborn screening programme. Based on the exceeded levels of the specific biomarker C4-acylcarnitine as well as ethylmalonic acid, we revealed a high prevalence of short-chain acyl-CoA dehydrogenase deficiency cases, confirmed by the findings of two rare pathogenic variants. A deletion c.310_312delGAG and c.1138C > T substitution in the ACADS gene appear with a high frequency in the Roma ethnic group of Slovakia. Due to the uncertainty of the pathogenicity and clinical consequences, it is important to follow up the morbidity and mortality in these patients over time and evaluate SCADD in relation to clinical outcomes and preventive healthcare recommendations.Keywords
This publication has 22 references indexed in Scilit:
- Clinical aspects of short‐chain acyl‐CoA dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 2010
- Mechanisms of Toxicity in Fatty Acid Oxidation DisordersPublished by Wiley ,2009
- Reccurent respiratory infects with respiratory failure caused by congenital myasthenic syndrome with homozygous mutation 1267delG in CHRNE geneEuropean Journal of Paediatric Neurology, 2008
- The 625G>A SCAD gene variant is common but not associated with increased C4‐carnitine in newborn blood spotsJournal of Inherited Metabolic Disease, 2004
- Screening Newborns for Inborn Errors of Metabolism by Tandem Mass SpectrometryThe New England Journal of Medicine, 2003
- Role of Common Gene Variations in the Molecular Pathogenesis of Short-Chain Acyl-CoA Dehydrogenase DeficiencyPediatric Research, 2001
- Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduriaHuman Molecular Genetics, 1998
- Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients.JCI Insight, 1987
- The diagnosis and biochemical investigation of a patient with a short chain fatty acid oxidation defectJournal of Inherited Metabolic Disease, 1985
- Short-Chain Acyl-CoA Dehydrogenase Deficiency Associated with a Lipid-Storage Myopathy and Secondary Carnitine DeficiencyThe New England Journal of Medicine, 1984